Tremor
Tremor is defined as an involuntary, rhythmic, oscillatory movement of a body part, typically resulting from alternating or synchronous contractions of reciprocally innervated muscles. It is among the most common movement disorders encountered in clinical practice and may arise from a variety of etiologies, including neurological, metabolic, and pharmacological factors. The pathogenesis of tremor involves complex interactions within the central nervous system, particularly within the cerebello-thalamo-cortical circuits, basal ganglia, and their associated neurotransmitter systems. Disruption or dysregulation of these neural pathways leads to abnormal rhythmic firing patterns, manifesting as tremor. The health impacts of tremor extend beyond the physical symptoms, often resulting in significant functional impairment, social embarrassment, psychological distress, and reduced quality of life, particularly when the tremor interferes with daily activities such as writing, eating, or personal care.
Essential tremor is the most prevalent form of pathological tremor, characterized by a bilateral, largely symmetric postural or kinetic tremor most commonly affecting the hands and forearms, although it may also involve the head, voice, or other body parts. The tremor is typically absent at rest and becomes apparent during voluntary movements or when maintaining a posture. Essential tremor often has a familial component, suggesting a genetic predisposition, and may progressively worsen over time.
Parkinsonian tremor is a classic resting tremor associated with Parkinson's disease, often described as 'pill-rolling' due to its characteristic movement of the thumb and index finger. It usually presents unilaterally at onset, most commonly in the hands, and may spread to other limbs or the jaw. The tremor typically diminishes with voluntary movement and increases during periods of rest or emotional stress. It is frequently accompanied by other parkinsonian features such as bradykinesia, rigidity, and postural instability.
Cerebellar tremor is an intention tremor that occurs during purposeful movement, particularly as the individual approaches a target (terminal intention). It is most often associated with lesions or dysfunction of the cerebellum or its pathways, resulting from conditions such as multiple sclerosis, stroke, or tumors. Cerebellar tremor is typically slow, coarse, and may be accompanied by other cerebellar signs such as dysmetria, ataxia, and nystagmus.
Physiological tremor is a normal, low-amplitude, high-frequency tremor present in all individuals, though usually not visible to the naked eye. It can become exaggerated (enhanced physiological tremor) under certain conditions such as anxiety, fatigue, hypoglycemia, hyperthyroidism, or with the use of stimulants. Enhanced physiological tremor is generally reversible upon removal of the precipitating factor.
Dystonic tremor occurs in individuals with dystonia, a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal postures or repetitive movements. The tremor is often irregular, variable in amplitude and frequency, and typically affects the body part involved in dystonia. It may be alleviated by sensory tricks (geste antagoniste) and can be task-specific.
Orthostatic tremor is a rare disorder characterized by a rapid (high-frequency, 13–18 Hz) tremor of the legs and trunk that occurs upon standing and resolves when sitting or walking. Patients often report unsteadiness or a sense of impending fall while standing, but overt tremor may not be visible and is best detected with electromyography.
Tremor is the most prevalent movement disorder globally, with essential tremor affecting approximately 0.4% to 5% of the general population, and its prevalence increases with advancing age, reaching up to 14% in individuals over 65 years. Parkinsonian tremor, as part of Parkinson's disease, has an estimated prevalence of 0.3% in the general population and about 1% in those over 60 years. There is no significant gender predilection for essential tremor, but a slight male predominance is observed in Parkinson's disease. Cerebellar and dystonic tremors are less common and are typically associated with their underlying etiologies. Enhanced physiological tremor is transient and widespread, while orthostatic tremor remains rare, with a prevalence estimated at less than 1 per 100,000. The burden of tremor is substantial, contributing to disability, loss of independence, and increased healthcare utilization, particularly among the elderly.
The diagnosis of tremor is primarily clinical, based on a thorough neurological examination and detailed patient history, including onset, duration, progression, family history, and exposure to potential tremor-inducing substances or medications. Characterization of the tremor involves assessing its frequency, amplitude, distribution, activation conditions (rest, posture, action), and associated neurological signs. Essential tremor is typically diagnosed by exclusion, requiring the presence of bilateral action tremor of the hands and forearms for at least three years, absence of other neurological signs, and no evidence of secondary causes. Parkinsonian tremor is identified by its resting nature, associated parkinsonian features, and response to dopaminergic therapy. Cerebellar tremor is suggested by intention tremor and accompanying cerebellar deficits. Ancillary investigations may include laboratory tests to exclude metabolic or toxic causes, neuroimaging (MRI or CT) to identify structural lesions, and electrophysiological studies (tremor analysis, electromyography) to quantify tremor characteristics. In select cases, genetic testing may be warranted for inherited forms. Standardized rating scales, such as the Fahn-Tolosa-Marin Tremor Rating Scale or the Unified Parkinson’s Disease Rating Scale, are utilized to assess severity and monitor treatment response.
Propranolol hydrochloride is a non-selective beta-adrenergic blocker that has been widely used as a first-line pharmacological treatment for essential tremor. It acts by reducing the amplitude of tremor, particularly in cases of action or postural tremor, and is most effective in upper limb involvement. Propranolol hydrochloride is administered orally and its efficacy has been demonstrated in numerous clinical studies, providing symptomatic relief and improving functional outcomes for many patients with tremor.
| Structure | Generic Name | CAS Registry Number | Molecular Formula | Molecular Weight |
|---|---|---|---|---|
 | propranolol hydrochloride (Rec INNM; USAN; BANM; JAN) | 318-98-9; 525-66-6 (free base) | C16 H21 N O2 . Cl H | 295.804 |
Make Order
Experimental Scheme
Implementation
Conclusion
